166 related articles for article (PubMed ID: 15006908)
1. Pap screening in a U.S. health plan.
Insinga RP; Glass AG; Rush BB
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
[TBL] [Abstract][Full Text] [Related]
2. Pap smear screening in a health maintenance organization: 1986-1990.
Rolnick S; LaFerla JJ; Wehrle D; Trygstad E; Okagaki T
Prev Med; 1996; 25(2):156-61. PubMed ID: 8860280
[TBL] [Abstract][Full Text] [Related]
3. Screening for cervical cancer: will women accept less?
Sirovich BE; Woloshin S; Schwartz LM
Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
[TBL] [Abstract][Full Text] [Related]
4. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
5. Pap smear screening among urban Southwestern American Indian women.
Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
[TBL] [Abstract][Full Text] [Related]
6. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
[TBL] [Abstract][Full Text] [Related]
7. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
[TBL] [Abstract][Full Text] [Related]
10. English proficiency and physicians' recommendation of Pap smears among Hispanics.
De Alba I; Sweningson JM
Cancer Detect Prev; 2006; 30(3):292-6. PubMed ID: 16844320
[TBL] [Abstract][Full Text] [Related]
11. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
Echeverria SE; Carrasquillo O
Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
[TBL] [Abstract][Full Text] [Related]
12. Hispanic acculturation and utilization of cervical cancer screening in the US.
Shah M; Zhu K; Wu H; Potter J
Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
[TBL] [Abstract][Full Text] [Related]
13. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research.
Bowman JA; Redman S; Dickinson JA; Gibberd R; Sanson-Fisher RW
Health Serv Res; 1991 Apr; 26(1):97-107. PubMed ID: 2016170
[TBL] [Abstract][Full Text] [Related]
14. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
Koval AE; Riganti AA; Foley KL
N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
[TBL] [Abstract][Full Text] [Related]
15. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening among women aged 18-30 years - United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1038-42. PubMed ID: 23282861
[TBL] [Abstract][Full Text] [Related]
17. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts.
Zapka JG; Puleo E; Taplin S; Solberg LI; Mouchawar J; Somkin C; Geiger AM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):46-54. PubMed ID: 16287885
[TBL] [Abstract][Full Text] [Related]
18. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
Eltoum IA; Roberson J
Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
[TBL] [Abstract][Full Text] [Related]
19. Use of laboratory reports to assess cervical cancer screening in a community.
Orr ST; Celentano DD; Hill G; Erozan YS; Shediac M; Correa-Villasenor A; Matanoski G
Am J Prev Med; 1994; 10(4):235-7. PubMed ID: 7803067
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
Kulasingam SL; Myers ER; Lawson HW; McConnell KJ; Kerlikowske K; Melnikow J; Washington AE; Sawaya GF
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
